IBD 50 Stalwart Jumps As It Views $3 Billion In 2025 As Feasible

IBD 50 Stalwart Jumps As It Views $3 Billion In 2025 As Feasible

Veeva easily topped first-quarter and 2020 guidance expectations Thursday, and shares of Veeva popped on Friday. The company expects to hit its $3 billion revenue goal in 2025.